Literature DB >> 20970314

Adoption and utilization of sexually transmitted infections testing in outpatient substance abuse treatment facilities serving high risk populations in the U.S.

Erick G Guerrero1, Julie A Cederbaum.   

Abstract

BACKGROUND: Although adoption and utilization of sexually transmitted infection (STI) testing is a cost effective public health intervention, it is inconsistently offered or referred out for by outpatient substance abuse treatment (OSAT) programs where at-risk racial/ethnic and sexual minorities receive services.
METHODS: We explored the organizational adoption and client utilization of STI testing using a nationally representative sample of OSAT facilities in the U.S. in 2005 (N=566). Data missing at random was imputed and the resulting database was analysed using multivariate Tobit and logistic regressions.
RESULTS: The analyses suggest that private non-profit facilities, which are the largest providers of OSAT treatment are less likely than public facilities to offer STI testing or to report adequate client utilization rates. Higher utilization was instead associated with professionally accredited facilities, and with facilities whose majority of clients were Latino/a, reported a history of treatment, stayed in treatment longer, or received case management.
CONCLUSION: While OSAT facilities are poised to be primary intervention points for diagnosis and treatment of STIs, only a segment of these facilities provide this preventive practice or manage to refer clients out. As such, U.S. health care policy should ensure the adoption and comprehensive utilization, particularly among high risk clients, of this cost-effective prevention strategy in OSAT admission protocols.
Copyright © 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20970314      PMCID: PMC3031721          DOI: 10.1016/j.drugpo.2010.09.005

Source DB:  PubMed          Journal:  Int J Drug Policy        ISSN: 0955-3959


  51 in total

1.  Sexual and drug behavior patterns and HIV and STD racial disparities: the need for new directions.

Authors:  Denise Dion Hallfors; Bonita J Iritani; William C Miller; Daniel J Bauer
Journal:  Am J Public Health       Date:  2006-11-30       Impact factor: 9.308

2.  Do licensing and accreditation matter in outpatient substance abuse treatment programs?

Authors:  Rebecca Wells; Christy H Lemak; Jeffrey A Alexander; Tammie A Nahra; Yining Ye; Cynthia I Campbell
Journal:  J Subst Abuse Treat       Date:  2007-01-16

3.  State policies matter: the case of outpatient drug treatment program practices.

Authors:  Jamie F Chriqui; Yvonne Terry-McElrath; Duane C McBride; Shelby S Eidson
Journal:  J Subst Abuse Treat       Date:  2007-10-23

Review 4.  Epidemiology of STD disparities in African American communities.

Authors:  Lori M Newman; Stuart M Berman
Journal:  Sex Transm Dis       Date:  2008-12       Impact factor: 2.830

5.  Behavioral counseling to prevent sexually transmitted infections: U.S. Preventive Services Task Force recommendation statement.

Authors: 
Journal:  Ann Intern Med       Date:  2008-10-07       Impact factor: 25.391

6.  Factors associated with the prevalence and incidence of Trichomonas vaginalis infection among African American women in New York city who use drugs.

Authors:  Maureen Miller; Yuyan Liao; Anu Manchikanti Gomez; Charlotte A Gaydos; Delysha D'Mellow
Journal:  J Infect Dis       Date:  2008-02-15       Impact factor: 5.226

7.  Alcohol, drugs, and condom use among drug offenders: an event-based analysis.

Authors:  Barbara C Leigh; Susan L Ames; Alan W Stacy
Journal:  Drug Alcohol Depend       Date:  2007-10-24       Impact factor: 4.492

8.  Moving upstream: ecosocial and psychosocial correlates of sexually transmitted infections among young adults in the United States.

Authors:  Anne L Buffardi; Kathy K Thomas; King K Holmes; Lisa E Manhart
Journal:  Am J Public Health       Date:  2008-04-29       Impact factor: 9.308

9.  Associations between alcohol, heroin, and cocaine use and high risk sexual behaviors among detoxification patients.

Authors:  Anita Raj; Richard Saitz; Debbie M Cheng; Michael Winter; Jeffrey H Samet
Journal:  Am J Drug Alcohol Abuse       Date:  2007       Impact factor: 3.829

10.  Health services for HIV/AIDS, HCV, and sexually transmitted infections in substance abuse treatment programs.

Authors:  Lawrence S Brown; Steven Kritz; R Jeffrey Goldsmith; Edmund J Bini; Jim Robinson; Donald Alderson; John Rotrosen
Journal:  Public Health Rep       Date:  2007 Jul-Aug       Impact factor: 2.792

View more
  9 in total

1.  Patient characteristics and availability of onsite non-rapid and rapid HIV testing in US substance use disorder treatment programs.

Authors:  Amanda J Abraham; Lauren A O'Brien; Hannah K Knudsen; Brian E Bride; G Rush Smith; Paul M Roman
Journal:  J Subst Abuse Treat       Date:  2012-04-25

2.  Provision of onsite HIV Services in Substance Use Disorder Treatment Programs: A Longitudinal Analysis.

Authors:  Lydia Aletraris; Paul M Roman
Journal:  J Subst Abuse Treat       Date:  2015-04-13

Review 3.  A Critical Review and Commentary on the Challenges in Engaging HIV-Infected Latinos in the Continuum of HIV Care.

Authors:  Julie H Levison; Julia K Levinson; Margarita Alegría
Journal:  AIDS Behav       Date:  2018-08

4.  Women, drugs and HIV.

Authors:  Tasnim Azim; Irene Bontell; Steffanie A Strathdee
Journal:  Int J Drug Policy       Date:  2014-09-17

5.  Workforce diversity in outpatient substance abuse treatment: the role of leaders' characteristics.

Authors:  Erick G Guerrero
Journal:  J Subst Abuse Treat       Date:  2012-06-02

6.  Organizational capacity for service integration in community-based addiction health services.

Authors:  Erick G Guerrero; Gregory A Aarons; Lawrence A Palinkas
Journal:  Am J Public Health       Date:  2014-02-13       Impact factor: 9.308

7.  HIV infection among people who inject drugs: the challenge of racial/ethnic disparities.

Authors:  Don C Des Jarlais; Dennis McCarty; William A Vega; Heidi Bramson
Journal:  Am Psychol       Date:  2013 May-Jun

8.  Correlates of having never been HIV tested among entrants to substance abuse treatment clinics: empiric findings from real-world New England settings.

Authors:  Jeanne J Chadwick; Leonardo F Andrade; Frederick L Altice; Nancy M Petry
Journal:  J Psychoactive Drugs       Date:  2014 Jul-Aug

9.  Nonmedical prescription drug users in private vs. public substance abuse treatment: a cross sectional comparison of demographic and HIV risk behavior profiles.

Authors:  Catherine L O'Grady; Hilary L Surratt; Steven P Kurtz; Maria A Levi-Minzi
Journal:  Subst Abuse Treat Prev Policy       Date:  2014-02-04
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.